captured official filings
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY
INNOCAN PHARMA Corp
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
WHAT THIS AUTOMATES
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
PROFESSIONAL DELIVERY LAYER
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
MACHINE-DETECTED FILING CHANGE RADAR
Public registration text delta
Comparing F-1 filed 2026-03-16 with F-1/A filed 2026-04-03.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- No tracked keyword-count change was detected in the cached plain-text excerpts.
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
New in latest filing
- On April 2, 2026, the last reported sale price of our common shares was CAD$6.60 (approximately $4.73) per share.
- Our common shares are also quoted on the OTCQB Venture Market under the ticker symbol “INNPF,” and on the Frankfurt Stock Exchange, or FSE, under the symbol “IP4.” The last reported sale price of our common shares on the OTCQB on April 2, 2026 was $4.95, and the last reported sale price of our common shar
- Our audited financial statements for the year ended December 31, 2025, contain an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.
Present in earlier filing, not found in latest
- On March 6, 2026, the last reported sale price of our common shares was CAD$5.9 (approximately $4.32) per share.
- Our common shares are also quoted on the OTCQB Venture Market under the ticker symbol “INNPF,” and on the Frankfurt Stock Exchange, or FSE, under the symbol “IP4.” The last reported sale price of our common shares on the OTCQB on March 6, 2026 was $4.34, and the last reported sale price of our common shar
- Our audited financial statements for the year ended December 31, 2024, contain an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
DOWNLOAD EDITION
Turn this issuer page into a project-file deliverable.
US$29 one time. For the moment you need to preserve the official record, hand it to a colleague or attach it to a deal file. No subscription, account or recurring charge. Download begins in this browser after payment is verified.
- Source-linked filing chronology and registration path
- Filing-change radar plus financing, legal, tax/lien and regulatory disclosure cues
- Official-source index for project-file archiving and downloadable CSV export
Best used whenYou need a dated, source-linked issuer record for a client, counsel, broker-dealer or internal review file.
Pay once · verified PayPal checkout · immediate HTML and CSV delivery.
AUTOMATED EVIDENCE SNAPSHOT
Unlock download · US$29Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
PUBLIC-RECORD DISCLOSURE SCREEN
Financing, legal and disclosure cues
Machine screening of the latest readable SEC filing text. It surfaces language for review; it does not label an issuer, confirm an event or produce a risk score.
TERM CUES OBSERVED147
Financing disclosure cues
Convertible instruments, placements and financing-agreement wording in screened SEC filing text.
- F-1/A · 2026-04-03 · SEC source
“…h were vested as of such date; ● 127,391 common shares issuable upon the conversion of the secured convertible debenture issued in March 2025, based on a conversion price of CAD$13.65 per share (approximately, $9.75 per share, based on the exchange rate reported by the Bank of Canada on May 14…”
- F-1 · 2026-03-16 · SEC source
“…h were vested as of such date; ● 127,391 common shares issuable upon the conversion of the secured convertible debenture issued in March 2025, based on a conversion price of CAD$13.65 per share (approximately, $9.75 per share, based on the exchange rate reported by the Bank of Canada on May 14…”
TERM CUES OBSERVED13
Legal-proceeding disclosure cues
Litigation and legal-proceedings wording in screened SEC filing text.
- F-1/A · 2026-04-03 · SEC source
“…and creating a new manufacturer discount program. It is unclear how the Supreme Court ruling, other such litigation and the healthcare reform measures of the Biden administration or the incoming Trump administration will impact the ACA and our business. Other legislative changes have been proposed a…”
- F-1 · 2026-03-16 · SEC source
“…and creating a new manufacturer discount program. It is unclear how the Supreme Court ruling, other such litigation and the healthcare reform measures of the Biden administration or the incoming Trump administration will impact the ACA and our business. Other legislative changes have been proposed a…”
NO TERM CUE OBSERVED0
Tax / lien disclosure cues
Tax-liability and lien wording in screened SEC filing text.
No matching term was found in the 4 readable SEC filings screened.NO TERM CUE OBSERVED0
Regulatory disclosure cues
Agency inquiry, enforcement and trading-status wording in screened SEC filing text.
No matching term was found in the 4 readable SEC filings screened.View screened SEC sources (4)
Coverage boundary: this is a keyword screen of selected SEC filings only. It is not a court-docket search, tax-compliance review, lien clearance, sanctions screen, adverse-media search or a complete count of financings. A zero result means no matching term in the readable documents screened—not that the underlying issue is absent. Verify each cue in the linked official filing and use the appropriate independent professionals.
CAPITAL & OFFERING RECORD
Browse all captured financing filings →Official filing path for financing review
Registration, amendment, prospectus, shelf and current-report nodes are organized here as a reading path. Use the SEC source for terms, status and materiality.
- F-1/ARegistration amendmentOpen SEC source →
- F-1Initial registration statementOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1/ARegistration amendmentOpen SEC source →
- F-1Initial registration statementOpen SEC source →
Interpretation boundary: filing counts are not financing-round counts, proceeds, closing status or current capitalization. A registration, prospectus or report can relate to different purposes; use the linked official filing and appropriate advisers to verify each event.
KEY OFFERING LANGUAGE
What the latest offering documents say
Candidate sentence excerpts from readable official SEC filing text. This provides a fast reading layer for offering structure and terms; it is not a normalized term sheet or a transaction conclusion.
Offering structure
Candidate language describing the securities or registration structure.
“For each pre-funded unit we sell, the number of units we are offering will be decreased on a one-for-one basis.”F-1/A · 2026-04-03 · Open SEC source →
Shares / price
Candidate language about shares, units or offering-price terms.
“The anticipated initial public offering price is between $5.00 and $6.00 per unit.”F-1/A · 2026-04-03 · Open SEC source →
Use of proceeds
Candidate language describing stated proceeds or intended use.
“Use of proceeds We expect to receive approximately $17.98 million in net proceeds from the sale of common shares offered by us in this offering (approximately $20.82 million if the underwriter exercises its over-allotment option in full), based upon an assumed public offering price of $5.50 per unit, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting the underwriting di”F-1/A · 2026-04-03 · Open SEC source →
Convertible / warrant terms
Candidate language about conversion, warrants or related instruments.
“The debenture unit consists of: (i) one secured convertible debenture in the principal amount of $1,000,000, and (ii) a warrant to purchase 85,470 common shares.”F-1/A · 2026-01-07 · Open SEC source →
View offering documents screened (5)
Extraction boundary: wording can be incomplete, duplicated, conditional or superseded by later filings. The system does not calculate proceeds, share counts, dilution or closing status from these excerpts. Verify every term in the linked official SEC filing.
OFFICIAL SEC SUBMISSIONS
Open Evidence Snapshot →Captured filing chronology
- F-1/ARegistration & offeringOpen SEC filing →
- F-1Registration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1Registration & offeringOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.